$12.49
5.31% yesterday
Nasdaq, Dec 04, 10:00 pm CET
ISIN
US78349D1072
Symbol
RXST

RxSight Inc Stock price

$12.49
+3.49 38.78% 1M
-2.77 18.15% 6M
-21.89 63.67% YTD
-30.67 71.06% 1Y
-1.34 9.69% 3Y
-3.51 21.94% 5Y
-3.51 21.94% 10Y
-3.51 21.94% 20Y
Nasdaq, Closing price Thu, Dec 04 2025
+0.63 5.31%

Key metrics

Basic
Market capitalization
$487.6m
Enterprise Value
$260.2m
Net debt
positive
Cash
$227.5m
Shares outstanding
41.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.4 | 3.8
EV/Sales
1.8 | 2.0
EV/FCF
negative
P/B
1.8
Financial Health
Equity Ratio
88.3%
Return on Equity
-9.8%
ROCE
-15.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$142.1m | $128.0m
EBITDA
$-42.5m | $-47.5m
EBIT
$-45.5m | $-60.1m
Net Income
$-35.7m | $-51.5m
Free Cash Flow
$-22.2m
Growth (TTM | estimate)
Revenue
10.8% | -8.5%
EBITDA
-9.0% | -28.9%
EBIT
-16.4% | -63.1%
Net Income
-16.4% | -87.7%
Free Cash Flow
18.3%
Margin (TTM | estimate)
Gross
75.0%
EBITDA
-29.9% | -37.1%
EBIT
-32.0%
Net
-25.2% | -40.3%
Free Cash Flow
-15.6%
More
EPS
$-0.9
FCF per Share
$-0.5
Short interest
11.2%
Employees
498
Rev per Employee
$280.0k
Show more

Is RxSight Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

RxSight Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a RxSight Inc forecast:

1x Buy
6%
10x Hold
63%
5x Sell
31%

Analyst Opinions

16 Analysts have issued a RxSight Inc forecast:

Buy
6%
Hold
63%
Sell
31%

Financial data from RxSight Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
142 142
11% 11%
100%
- Direct Costs 36 36
12% 12%
25%
107 107
21% 21%
75%
- Selling and Administrative Expenses 113 113
20% 20%
80%
- Research and Development Expense 39 39
20% 20%
27%
-43 -43
9% 9%
-30%
- Depreciation and Amortization 2.94 2.94
4,100% 4,100%
2%
EBIT (Operating Income) EBIT -45 -45
16% 16%
-32%
Net Profit -36 -36
16% 16%
-25%

In millions USD.

Don't miss a Thing! We will send you all news about RxSight Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RxSight Inc Stock News

Neutral
GlobeNewsWire
14 days ago
ALISO VIEJO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – November 20, 2025 – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City.
Neutral
Seeking Alpha
29 days ago
RxSight, Inc. ( RXST ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Oliver Moravcevic Ronald Kurtz - Co-President, CEO & Director Shelley Thunen - Co-President & CFO Conference Call Participants Iseult McMahon - BTIG, LLC, Research Division David Saxon - Needham & Company, LLC, Research Division Gursimran Kaur - Wells Fargo Securities, LLC, Research Division Patrick W...
Neutral
GlobeNewsWire
29 days ago
ALISO VIEJO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended September 30, 2025.
More RxSight Inc News

Company Profile

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery The company was founded by Robert Grubbs and Daniel Schwartz on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Head office United States
CEO Ronald Kurtz
Employees 498
Founded 1997
Website www.rxsight.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today